FDA discouraging use of power morcellation

Deputy Editor Jon I. Einarsson, MD, PhD, MPH, offers perspective on a safety communication discouraging use of power morcellation during hysterectomy or myomectomy for fibroids that was issued by the Food and Drug Administration (FDA) because of concern about risk of inadvertent spread of unsuspected cancer to abdominal and pelvic cavities. » More

• The transcervical Foley balloon

• Unbilical cord prolapse

• Isolated fetal choroid plexus cysts

POLL

Tell us: Ob/gyns, do you recommend screening mammography to patients aged 40 to 59?

- Yes
- No